Review Series on Multiple Myeloma Update 2025, Guest Editor: Pellegrino Musto

REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Dr. Enrica A. Martino, Dr. G. Mele, Dr. F. Morabito, Dr. M. Gentile, Dr. E. Vigna

Page e2025006 DOI: https://doi.org/10.4084/MJHID.2025.006    PDF      HTML

 

HOW FIRST-LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS

Yasmine Houbaida, Maria Livia Del Giudice, Sara Galimberti, Gabriele Buda

Page e2025026   PDF         HTML        DOI: https://doi.org/10.4084/MJHID.2025.026

 

HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS.

Fazio F., Deiana L., Loi C., Mura F., Petrucci M.T., Derudas  D.

Page e2025025     PDF           HTML   DOI: https://doi.org/10.4084/MJHID.2025.025

 

NOVELTIES ON MULTIPLE MYELOMA FROM THE MAIN 2024 HEMATOLOGY CONFERENCES

Sonia Morè, Laura Corvatta, Valentina Maria Manieri, Erika Morsia, Antonella Poloni, Massimo Offidani

Page e2025027     PDF          HTML         DOI: https://doi.org/10.4084/MJHID.2025.027